Co-Founder, CEO of HemaCore, Member of Board of several companies.
14 years business experience - CTO, CMO, CEO. 7 years innovation projects experience. Raised ~$22M investments.
HemaCore - biotech company, develops new medical devices and methods for hematology. Company was invested by RUSNANO to bring to the market 鈥淭hrombodynamics鈥� 鈥� new global assay for monitoring and prognosis of blood clotting disorders: bleeding and thrombosis (precursors of heart attacks and strokes)
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
